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ABSTRACT
Stress and elevated cortisol levels are associated with pathological
heart growth and cardiovascular disease in humans and other
mammals. We recently established a link between heritable variation
in post-stress cortisol production and cardiac growth in salmonid fish
too. A conserved stimulatory effect of the otherwise catabolic steroid
hormone cortisol is probably implied, but has to date not been
established experimentally. Furthermore, whereas cardiac growth is
associated with failure of the mammalian heart, pathological cardiac
hypertrophy has not previously been described in fish. Here, we show
that rainbow trout (Oncorhynchus mykiss) treated with cortisol in the
diet for 45 days have enlarged hearts with lower maximum stroke
volume and cardiac output. In accordance with impaired cardiac
performance, overall circulatory oxygen-transporting capacity was
diminished as indicated by reduced aerobic swimming performance.
In contrast to the well-known adaptive/physiological heart growth
observed in fish, cortisol-induced growth is maladaptive. Furthermore,
the observed heart growth was associated with up-regulated signature
genes of mammalian cardiac pathology, suggesting that signalling
pathways mediating cortisol-induced cardiac remodelling in fish are
conserved from fish to mammals. Altogether, we show that excessive
cortisol can induce pathological cardiac remodelling. This is the first
study to report and integrate the etiology, physiology and molecular
biology of cortisol-induced pathological remodelling in fish.
KEYWORDS: Myocardial hypertrophy, Chronic stress, Heart failure,
Rainbow trout, Cardiac performance
INTRODUCTION
Cardiovascular disease is the leading cause of death in the western
world. In addition to classical risk factors (e.g. hypertension and
elevated levels of blood cholesterol), epidemiological evidence and
common folklore wisdom suggest an association between stress and
coronary heart disease risk in humans (Rosengren et al., 1991, 2004;
Iso et al., 2002). It is also well known that individual variation in
physiology and behaviour (coping styles or ‘personalities’) predicts
disease outcome in both animal models and humans (Denollet et al.,
1996). Mechanisms underlying stress-induced cardiac pathology
risk remain largely unknown; however, increased levels of the
steroid hormone cortisol are believed to be important. For example,
high cortisol responsiveness to stress is associated with a fourfold
increased risk of cardiovascular morbidity and mortality in humans
(Denollet, 2000) and clinical use of synthetic cortisol (i.e. cortisone,
hydrocortisone, dexamethasone, etc.) is associated with abnormal
heart growth and other cardiovascular diseases (Souverein et al.,
2004). In mammalian experimental models, glucocorticoids like
cortisol directly induce cardiomyocyte hypertrophy in vitro
(Whitehurst et al., 1999; Ren et al., 2012) and in vivo (Clark
et al., 1982; de Vries et al., 2002; Jensen et al., 2002; Lumbers et al.,
2005), indicating a direct role of cortisol in heart remodelling,
growth and disease.
Stress- and cortisol-induced cardiac hypertrophy may not be
limited to mammals. Cardiac remodelling and deformities are
commonly reported in farmed fish (Poppe et al., 2007), but a link
between stress and development of such diseases has never been
established. As in humans, the main glucocorticoid and stress
hormone in salmonid fish is cortisol. We previously established a
link between cortisol responsiveness to stress and cardiac
remodelling in rainbow trout (Oncorhynchus mykiss) high
responsive (HR) and low responsive (LR) strains and wild-type
brown trout (Salmo trutta) (Johansen et al., 2011). High post-stress
cortisol production is also associated with a range of behavioural
and cognitive traits indicating a reactive coping style (Øverli et al.,
2005, 2007; Sørensen et al., 2013), rendering the salmonids a
productive model to study proximate physiological mechanisms
underlying consistent trait associations (Khan et al., 2016).
Regarding cardiac function, individuals responding to stress with
high cortisol levels (HR fish) have notably larger ventricles
compared with individuals with a low cortisol response (LR fish).
Combined, previous findings indicate a common mechanism
behind cortisol-associated heart growth in fish and mammals,
suggesting either parallel evolution or conservation of important
regulatory mechanisms. Of note, although cardiac hypertrophy is
associated with failure of the mammalian heart (Lloyd-Jones et al.,
2002), the concept of pathological cardiac hypertrophy has not been
established in fish. In fact, cardiac growth is a routinely occurring
phenomenon in many fishes including salmonids, and is generally
considered an adaptive response that enhances myocardial
mechanical performance and cardiac pumping capacity (Graham
and Farrell, 1989) during, for example, seasonal cold acclimatizationReceived 20 November 2015; Accepted 2 May 2017
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(Klaiman et al., 2011) and sexual maturation (Franklin and Davie,
1992). Further, although an association between cortisol exposure
and cardiac remodelling has been observed in fish and mammals, the
direct effect of exogenous cortisol administration on cardiac
morphology and function has, to our knowledge, not been
investigated in fish.
Here, we hypothesized that chronic exposure to high cortisol
directly induces cardiac hypertrophy and impairs cardiac
performance in rainbow trout. Further, we hypothesized that
intracellular signalling pathways mediating cortisol-induced cardiac
remodelling in fish are similar to those involved in pathological
cardiac hypertrophy in mammals.
MATERIALS AND METHODS
Research animals and animal housing
Juvenile rainbow trout, Oncorhynchus mykiss (Walbaum 1792)
(150±29 g, mean±s.d.; obtained from Store Restrup Fiskeri, Nibe,
Denmark), were used for 45 and 90 days of cortisol treatment.
Experiments were conducted at the Danish Technical University,
Institute of Aquatic Resources, Hirtshals, Denmark. Prior to cortisol
treatment, fish were kept in rearing tanks (1000 l) supplied with
aerated tap water at 17°C, on a 14.5 h:9.5 h light:dark cycle. The fish
were subsequently moved and randomly distributed into six 700 l
cylinder tanks (45 fish per tank) and allowed to acclimatize for
5 days before the onset of cortisol treatment. During this period and
throughout the experiment, the tanks were supplied with aerated
recirculating water at 19°C. A 14.5 h:9.5 h light:dark cycle was
maintained. Fish were divided into four treatment groups: one tank
received control feed for 45 days (n=45), one tank received control
feed for 90 days (n=45), two duplicate tanks received cortisol-
treated feed for 45 days (n=90) and two duplicate tanks received
cortisol-treated feed for 90 days (n=90). Ethical approval for the
experiments was given by the Norwegian and Danish Animal
Research Authorities with licence numbers 2012/33240 and 2014-
15-2934-01041, respectively.
For in vivo assessment of effects of cortisol-induced remodelling
on cardiovascular performance, juvenile rainbow trout (420±23 g,
mean±s.d.), obtained from Antens laxodling AB, Alingsås, Sweden,
were used. Experiments were conducted at the fish holding facilities
at the Department of Biological and Environmental Sciences,
University of Gothenburg, Sweden. Fish were kept in tanks
supplied with partly recirculating UV-treated and bio-filtered
freshwater at 8°C prior to experimentation, on a 12 h:12 h light:
dark cycle. The experiments were covered by ethical permit 65-2012
with amendment 169-2013 from the local ethical committee in
Gothenburg. For all experiments, animals were randomly assigned to
either a control or a treatment group.
Preparation of cortisol feed
Cortisol treatment refers to oral administration of food pellets coated
with hydrocortisone. This diet was prepared by dissolving 500 mg
(dose modified from Sørensen et al., 2011) cortisol (hydrocortisone
powder, Sigma-Aldrich, St Louis, MO, USA) in 15 g rapeseed oil
(First Price, SuperGros A/S, Denmark) per kilogram of pellets
(EFICO Enviro 920, 3 or 6 mm depending on fish size; Biomar,
Brande, Denmark). This was mixed in a container rebuilt from an
850 W electric cement mixer (174 l) and thorough mixing of the
content was ensured by rotation of this mixer. The container was
connected to a vacuum pump and in order for the cortisol to be
absorbed into the pellets, a negative pressure of 0.9 bar (90 kPa) was
applied before air was slowly let back into the container. Control
feed was prepared in the same way but with pure rapeseed oil.
In vivo cortisol treatment
During acclimation, all fish were fed 0.8% of their total body mass
(Mb) each day with commercial pellets (EFICO Enviro 920, 3 mm,
Biomar). At the onset of the experiment, the feed was replaced with
pellets of the same brand and size that had been coated with either
rapeseed oil alone (control feed) or rapeseed oil and hydrocortisone
(see above) and the fish were fed 0.8% of their Mb daily,
corresponding to a dose of 4 µg cortisol g−1 Mb. Following 45
and 90 days of treatment, cortisol-treated fish appeared as healthy as
control fish with no internal or external symptoms of pathogen
infection.
Physiological measurements and sampling
For blood sampling, fish were lightly anaesthetized with 1 g l−1 MS-
222 (Sigma-Aldrich) before a blood sample was collected from the
caudal vein. The blood samples were centrifuged for 5 min at 4°C,
8000 g, and plasma was frozen and stored at −20°C for later analysis
of cortisol levels. Hearts from all experimental fish were surgically
excised and the bulbus and atrium removed. The ventricles were
blotted dry of blood and weighed on a precision scale, and
cardiosomatic index (CSI=ventricle wet mass/Mb) was calculated.
Images of the ventricles were taken using a Canon EOS350 digital
camera (Canon, Tokyo, Japan) and processed in Adobe Photoshop
CS3 (Adobe Systems Inc., San Jose, CA, USA).Ventricles were
placed in RNAlater® solution (Ambion, Austin, TX, USA) for 24 h at
room temperature before being stored at −20°C for later quantitative
PCR (qPCR) mRNA analysis, or put in freshly prepared 4%
paraformaldehyde for magnetic resonance imaging (MRI) analysis or
dried at 70°C for 24 h for analysis of water content.
Plasma cortisol analysis
Plasma cortisol was measured in a random selection of individuals
treated with cortisol for 15 and 45 days. Plasma cortisol was
analysed using radioimmunoassay (RIA) based on the assay by
Pottinger and Carrick (2001). In short, steroids were extracted with
ethyl acetate (Merck, Kenilworth, NJ, USA; 1:5 plasma:ethyl
List of symbols and abbreviations
ANP A-type natriuretic peptide
BNP B-type natriuretic peptide
CSI cardiosomatic index
fH heart rate
Hb haemoglobin
Hct haematocrit
Mb body mass
MLP muscle LIM protein
MRI magnetic resonance imaging
Mv ventricle mass
PCNA proliferating cell nuclear antigen
PDA dorsal aortic blood pressure
PDA,dia diastolic pressure
PDA,sys systolic pressure
_Q cardiac output
RCAN1 regulator of calcineurin 1
RIA radioimmunoassay
RIN RNA integrity number
Rsys systemic vascular resistance
SMLC2 slow myosin light chain 2
Ucrit critical swimming speed
VMHC ventricular myosin heavy chain
VS cardiac stroke volume
2546
RESEARCH ARTICLE Journal of Experimental Biology (2017) 220, 2545-2553 doi:10.1242/jeb.135046
Jo
u
rn
al
o
f
Ex
p
er
im
en
ta
lB
io
lo
g
y
acetate) prior to the RIA. A 5–150 μl sample of extract was
transferred to 1.5 ml Eppendorf tubes, and 50 μl [1,2,6,7-3H]
cortisol (∼16,000 cpm; Amersham Pharmacia Biotech, Little
Chalfont, UK, 60 Ci mmol−1) was added to all samples. The ethyl
acetate was evaporated in an exsiccator coupled to a water-jet pump
and donkey anti-cortisol antibody (AbD Serotec, Dusseldorf,
Germany) was added. After 18 h incubation at 4°C, dextran-
coated charcoal in PBS (1.0% activated charcoal, Sigma; 0.2%
dextran, Sigma) was added. Supernatant from each tube was
transferred to scintillation vials containing 4 ml scintillation fluid
(Ultima Gold, Perkin Elmer, Waltham, MA, USA), and counted on
a Packard Tri-Carb A1900 TR liquid scintillation analyser (Packard
Instrument, Meriden, CT, USA). A 3-parameter hyperbolic function
was fitted to the plot of the percentage of [3H]cortisol bound against
a standard curve using SigmaPlot 11 (SPSS Science, Systat
Software Inc., San Jose, CA, USA). The equation from this
function was used to estimate the cortisol concentration in the
unknown samples. The lower and upper detection limits of the assay
were 0.19 and 655 ng ml−1, respectively. For individuals where the
plasma cortisol levels were below this limit, the level was set to
0.19 ng ml−1.
MRI of fixed ventricles
Ventricles fixed in 4% paraformaldehyde were thoroughly rinsed
with saline water (0.4%) then mounted with cotton and soaked in
MRI-compatible perfluoropolyether oil (Fomblin, Sigma-Aldrich)
in a 15 mm glass tube. MRI experiments were performed on a pre-
clinical 9.4 T MRI system (Agilent Technologies, Palo Alto, CA,
USA) equipped with a high-performance gradient coil (inner
diameter 60 mm, maximum strength 1000 mT m−1) and a
quadrature radio frequency volume coil (19 mm i.d., Rapid
Biomedical, Rimpar, Germany). High resolution images were
acquired by 3D spoiled gradient echo. The field of view ranged from
12.8×12.8×12.8 mm to 16×16×16 mm depending on the size of the
specimen. Other typical parameters were matrix 1024×512×512,
repetition time 45 ms, echo time 10 ms, flip angle 45 deg, 5
averages, acquisition time 16 h 23 min. Fiji image processing
software (released under the General Public License) was employed
to view the images and measure the area of compact and non-
compact myocardium. Compact myocardium area was calculated
by subtracting non-compact area (area inside the compact layer in
the ventricle) from total area. Compact myocardium area was then
divided by non-compact myocardium area to get the ratio of
compact to non-compact area.
RNA extraction and qPCR analysis
Ventricles, stored and frozen in RNAlater® (see above), were thawed
and refrozen in liquid nitrogen before they were freeze-fractured in a
BioPulverizer (Biospec Products, Inc., Bartlesville, OK, USA). The
pulverized hearts were put into 15 ml plastic tubes and RNA was
extracted using TRIzol® reagent (Invitrogen, Carlsbad, CA, USA)
according to themanufacturer’s protocol. The quality and quantity of
the RNA was assessed using a 2100 Bioanalyzer (Agilent
Technologies) and a NanoDrop® ND-1000 UV-Vis
Spectrophotometer (NanoDrop Technologies, Rockland, DE,
USA), respectively. RNA quality was determined from RNA
integrity numbers (RINs) calculated by the 2100 Bioanalyzer
(range: 1–10). The RIN for the tissue samples ranged from 8.4 to
10.0 with an average of 9.5, confirming excellent RNA quality. First-
strand cDNA was synthesized from total RNA treated with 2 ng
DNase I (DNA-freeTM Kit, Ambion) using Superscript III reverse
transcriptase (Invitrogen) with oligo dT12–18 primers synthesized by
Invitrogen. Gene-specific primer sequences for rainbow trout β-
actin, proliferating cell nuclear antigen (PCNA), ventricular myosin
heavy chain (VMHC), slow myosin light chain 2 (SMLC2), muscle
LIM protein (MLP), regulator of calcineurin 1 (RCAN1), A-type
natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) were
designed and published previously (Johansen et al., 2011). The
housekeeping gene β-actin was used as a reference gene. qPCR was
carried out using a Roche LC480 Light Cycler (Roche Diagnostics,
Penzberg, Germany). Reaction volumes were 10 µl and included
Light Cycler® 480 SYBR Green I Master (Roche Diagnostics),
primers (5 µmol l−1) and cDNA (3 µmol l−1). Cycling conditions
were as follows: 10 min at 95°C, 42 cycles of 10 s at 95°C, 10 s at
60°C and 10 s at 72°C, followed bymelt curve analysis. All reactions
were run in duplicate and controls without DNA template were
included to verify the absence of cDNA contamination.
Relative gene expression data were calculated from qPCR raw
data as the ratio of expression of the gene of interest (GOI) to that of
the internal control (IC, β-actin): ECpIC =E
Cp
GOI, where E is priming
efficiency and Cp is the crossing point. E-values were calculated for
each qPCR reaction using LinRegPCR software (version 11.30.0)
(Ruijter et al., 2009).
Surgical instrumentation for in vivo cardiovascular
measurements
Individual fish were netted from the holding tanks and anaesthetized
in aerated water containing 200 mg l−1 MS-222 (Sigma-Aldrich)
buffered with NaHCO3 (400 mg l−1). The fish were weighed and
placed on a surgery table covered with wet foam rubber. The gills
were continuously irrigated via the mouth with aerated water
(∼10°C) containing a lower dose of NaHCO3 (100 and 200 mg l−1)-
buffered MS-222. The right operculum was carefully retracted and
the ventral aorta was surgically exposed, taking care not to damage
the pericardium and adjacent small blood vessels and nerves. A 4-0
silk suture was placed under the vessel, which was carefully lifted
and a 2.5PSL or 2.5PSB Transonic perivascular blood flow probe
(Transonic Systems Inc., Ithaca, NY, USA), factory-calibrated to
10°C, was placed around the aorta to measure cardiac output ( _Q).
The lead from the flow probewas attached to the skin with several 2-
0 silk sutures close to the opercular cavity. The dorsal aorta was then
cannulated via the roof of the buccal cavity with a PE-50 catheter
using a sharpened steel wire as a guide (Axelsson and Fritsche,
1994). The catheter was rinsed and filled with heparinized
(100 IU ml−1) saline (0.9%) and closed with a pin. The catheter
and the flow probe lead were collectively sutured to the skin on the
back of the fish with a single 2-0 silk suture. Following surgery, fish
were revived in freshwater in their respective holding tank and
placed individually into a plastic tube floating in the tank. They were
left to recover from surgery for approximately 24 h before
experimentation commenced.
Experimental protocol for in vivo cardiovascular
measurements
The fish was removed from the holding tube and transferred using a
water-filled plastic bag to a round tank (diameter: 655 mm, volume:
75 l) supplied with through-flowing water (8°C). To trigger a
maximal cardiovascular response, fish were subjected to a manual
chase protocol where vigorous escape behaviours were encouraged
by repeatedly touching the body of the fish for 10 min, such that the
fish was completely unresponsive to physical stimuli at the end of
the protocol. The fish was then rapidly transferred to an opaque
holding chamber (length: 54 cm, width: 13 cm and depth: 18 cm)
with through-flowing water from the samewater system and covered
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to avoid external visual stimuli. A blood sample (0.5 ml) was
quickly withdrawn into a heparinized syringe from the dorsal aortic
cannula to determine maximal haematological status after stress,
and cardiovascular variables (maximal) were then recorded for
2–3 h after the chase protocol. The maximum cardiovascular
response was defined as the period when _Q peaked after the
exhaustive chase protocol. Typically, the maximum response
occurred within 15 min and reported data represent the means
from a 2 min period taken during the maximum response.
The following day, i.e. when the fish had recovered from the
preceding exercise protocol for ∼24 h, basal cardiovascular
variables were recorded for several hours. When low and stable
cardiovascular variables had been confirmed, another blood sample
(0.5 ml) was withdrawn into a heparinized syringe from the catheter
to determine basal haematological status. Cardiac autonomic tone
was then determined using the pharmacological protocol of
Altimiras et al. (1997). Briefly, atropine sulphate (1.2 mg kg−1
Mb) was injected via the catheter to block muscarinic receptors, and
cardiovascular variables were allowed to stabilize for 30–60 min
before a recording was made. Finally, (±)propranolol hydrochloride
(3 mg kg−1 Mb) was injected to block β-adrenergic receptors, and
cardiovascular variables were allowed to stabilize for at least 30 min
before a final recording was made.
Acquisition of cardiovascular variables and analytical
procedures
The dorsal aortic catheter was connected to a DPT-6100 blood
pressure transducer (pvb Medizintechnik, Kirchseeon, Germany)
that was calibrated against a static column of water and referenced to
the fluid in the holding tubes. A 4ChAmp pre-amplifier (Somedic
AB, Hörby, Sweden) was used to amplify the signal from the
transducer. The blood flow probe was connected to a three-channel
400 series Transonic blood flow meter (Transonic Systems Inc.).
Data were sampled at 100 Hz using a Power Lab unit
(ADInstruments Pty Ltd, Castle Hill, NSW, Australia) connected to
a laptop computer running LabChart Pro software (version 7.3,
ADInstruments Pty Ltd). From the pulsatile blood pressure signal,
mean dorsal aortic blood pressure (PDA), diastolic pressure (PDA,dia),
systolic pressure (PDA,sys), pulse pressure (PDA,pulse) and heart rate
( fH) were calculated using the blood pressure module in the LabChart
Pro software. _Q was calculated from the phasic blood flow signal,
and based on these primary variables cardiac stroke volume (VS)
was calculated as VS= _Q/fH and systemic vascular resistance (Rsys)
was calculated as Rsys=PDA/ _Q, assuming that central venous blood
pressure is close to zero and that changes in venous pressure are
negligible in these calculations (Sandblom and Axelsson, 2007).
Blood haematocrit (Hct) was determined in duplicate using
microcapillary tubes spun in a Hct centrifuge. Blood haemoglobin
(Hb) concentration was determined using a Hemocue Hb 201+ unit
(Hemocue® AB, Ängelholm, Sweden) with values corrected for
salmonid fish blood according to Clark et al. (2008).
Experimental protocol for assessing swimming performance
Critical swimming speed (Ucrit) was determined using a swimming
respirometer as described previously (Skov et al., 2011). The
swimming trials were conducted at the Danish Technical
University, Institute of Aquatic Resources, Hirtshals, Denmark,
and the temperature during trials was 19°C.
Statistical analyses
Data are expressed as group means±s.e.m. Differences between
cortisol-treated and the respective treatment controls were tested by
one-way ANOVA (for differences in plasma cortisol levels),
two-way ANOVA (for effects of treatment and sex on CSI) or
unpaired t-tests with Welch’s correction for unequal variance when
relevant. Average CSI, relative compact to non-compact tissue and
mRNA levels of control fish were normalized to 1, and data are
presented as normalized values to treatment control average (fold-
change), whereas other data are presented as absolute values.
P<0.05 was considered statistically significant. For all experiments,
a sample size ≥8 was used to ensure satisfactory statistical power.
All statistical analyses were performed in GraphPad Prism 6
(GraphPad Software, San Diego, CA, USA).
RESULTS
Chronic cortisol exposure induces cardiac hypertrophy in
rainbow trout
To test whether chronic cortisol exposure directly induces cardiac
remodelling in salmonid fish, rainbow trout were fed cortisol-
containing feed for 45 days. Increased plasma cortisol levels were
confirmed after 15 and 45 days of cortisol treatment by one-way
ANOVA (P<0.01). Mean (±s.e.m.) plasma cortisol concentration
after 15 days was 27.13±8.2 versus <0.19±0.0 µg l−1 (below
detection limit) in cortisol-treated (n=7) and control (n=5) fish,
respectively. After 45 days, plasma cortisol concentration equalled
20.38±5.49 versus 8.57±1.99 µg l−1 in cortisol-treated (n=14) and
control fish (n=14), respectively.
Consistent with our hypothesis, 45 days of cortisol treatment
resulted in a robust 34% increase in CSI compared with controls
(F1,52=80.93, P<0.001; Fig. 1B). Mean (±s.e.m.) CSI was 0.085±
0.002 for controls and 0.11±0.002 for cortisol-treated fish. As no
sex differences were identified by two-way ANOVA (F1,52=0.09,
P=0.77; Fig. S1), we did not distinguish between sexes in
subsequent analyses.
While visual inspection of ventricles gave a clear indication that
these were larger in cortisol-treated fish (illustrated in Fig. 1A), we
also compared absolute ventricular mass (Mv) and Mb in the two
treatment groups following 45 days of treatment to exclude that the
elevated CSI was attributed to reduced Mb. Indeed, absolute Mv of
cortisol-treated fish (0.22±0.01 g) was higher than that of controls
(0.20±0.01 g, P<0.05; Fig. 1C), despite absoluteMb being lower in
the cortisol-treated fish (198.1±6.2 versus 238.4±10.5 g, P<0.01;
Fig. 1D). Thus, while cortisol induced substantial cardiac growth,
overall somatic growth was stunted by cortisol treatment.
The salmonid heart consists of two separate layers of myocardium,
i.e. spongious and compact myocardium. The inner spongious
myocardium is supplied with blood from the venous circulation,
while the outer compact myocardium resembles the mammalian
myocardium and is supplied with blood from the coronary arteries
(Pieperhoff et al., 2009). The compact myocardium has a greater
force-generating capacity than the spongious myocardium. We
therefore assessed the relative proportion of compact to non-compact
volume in the two treatment groups by MRI of the ventricles (see
Fig. 1E). Interestingly, cortisol-treated fish had a higher proportion of
compact to non-compact myocardial volume compared with controls
(P<0.05; Fig. 1F), indicating that the cortisol-induced cardiac growth
is primarily due to growth of the compact myocardium. There was no
significant difference in myocardial water content between controls
and cortisol-treated fish, consistent with the increase in CSI not
resulting from myocardial tissue oedema (Fig. 1G).
To indicate whether the observed heart growth was due to
hypertrophy or hyperplasia (i.e. cell proliferation), cardiac mRNA
levels of the cell proliferation marker PCNAwere measured. PCNA
levels were not significantly increased by the cortisol treatment,
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suggesting that cortisol-induced heart growth was driven mainly by
hypertrophy (Fig. 1H).
Hypertrophic remodelling is associated with increased
expression of signature molecules of cardiac pathology
In mammals, including humans, pathological stimuli induce
hypertrophic growth and remodelling of the heart, characterized
by up-regulation of specific molecular markers. We investigated the
expression levels of SMLC2, VMHC,MLP, RCAN1, ANP and BNP
in ventricles of rainbow trout treated with cortisol for 45 days.
SMLC2 mRNA levels were doubled (P<0.05; Fig. 2A) in cortisol-
treated fish whereas a trend towards increased VHHC was observed
(P=0.14; Fig. 2B).
The mammalian stress-sensor MLP was similarly upregulated
(P<0.05; Fig. 2C) by the cortisol treatment. MLP is necessary for
stress-induced, pro-hypertrophic nuclear factor of activated T-cell
(NFAT) signalling in mammals (Heineke et al., 2003). Calcineurin–
NFAT signalling is a major pathway involved in mammalian
pathological hypertrophy and remodelling and we assessed its
activation by measuring mRNA levels of a direct downstream target
gene of NFAT, RCAN1. Interestingly, RCAN1 mRNA levels were
102% higher than in respective controls following cortisol treatment
(P<0.05; Fig. 2D). This indicates increased activation of pro-
hypertrophic NFAT signalling in rainbow trout hearts exposed to
chronically elevated cortisol levels.
Natriuretic peptides are well-known signature molecules of heart
failure progression in mammalian cardiac pathology (Lerman et al.,
1993; Maisel et al., 2002). In line with a pathological transcriptional
programme profile of cardiac remodelling in cortisol-treated rainbow
trout, mRNA levels ofANPwere upregulated (Fig. 2E). mRNA levels
of BNP were not significantly changed (Fig. 2F).
Chronic cortisol exposure impairs cardiovascular function
and aerobic swimming performance in rainbow trout
Upregulation of signature molecules of cardiac pathology indicate
that cortisol-induced heart growth is not functionally adaptive. To
test this, cardiovascular scope (i.e. the difference between maximum
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Fig. 1. Chronic cortisol exposure increases ventricular size in rainbow trout. (A) Image of ventricles of fish treated with cortisol for 45 days (244 g Mb and
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cell nuclear antigen (PCNA) relative to the standard gene β-actin following 45 days of cortisol treatment (ncontrol=9, ncortisol=10). Data are either
means±s.e.m. (C,D,G) or means±s.e.m. relative to treatment control (B,F,H). Themean CSI, ratio of compact to non-compact myocardium and PCNA expression
of control fish were normalized to 1. Statistical differences were tested by two-way ANOVA (for CSI) or unpaired two-tailed t-tests. *P<0.05 versus control;
**P<0.01 versus control; ***P<0.001 versus control.
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Fig. 2. Cortisol-induced hypertrophic remodelling is associated with
increased expression of signature molecules of cardiac pathology in
rainbow trout. mRNA abundance of (A) slow myosin light chain 2 (SMLC2),
(B) ventricular myosin heavy chain (VMHC), (C) muscle LIM protein (MLP),
(D) regulator of calcineurin 1 (RCAN1), (E) A-type natriuretic peptide (ANP)
and (F) B-type natriuretic peptide (BNP) relative to the standard gene β-actin
following 45 days of cortisol treatment (ncontrol=9, ncortisol=10). Data are means
±s.e.m. relative to control. Statistical differences were tested by unpaired
two-tailed t-tests. *P<0.05 versus control.
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and resting values) was assessed in vivo in a separate cohort of
rainbow trout treated with cortisol for 45 days. To trigger a maximal
cardiovascular response, fish were subjected to a period of
exhaustive exercise. Maximum cardiovascular performance was
assessed when _Q was maximal immediately after the exhaustive
exercise. Resting cardiovascular values were then assessed
following a 24 h recovery period.
Despite having larger ventricles [mean±s.e.m. CSI was 0.12±
0.009 versus 0.085±0.003 in cortisol-treated (n=13) and control
(n=20) fish, P<0.001] with more compact myocardium, maximum _Q
(P<0.05) was lower in cortisol-treated fish. Resting _Q was not
significantly changed but _Q scope (P<0.05) was also lower in the
cortisol group (Fig. 3A). Similarly, maximum but not resting VS was
lower in cortisol-treated fish, and there was a clear trend (P=0.55) for
a reduced VS scope (Fig. 3B). There was no significant difference in
maximum fH between treatment groups, but resting fH was higher in
cortisol-treated fish (P<0.05; Fig. 3C), which meant that the fH scope
was reduced (P<0.05) in this group (Fig. 3C).
The observed increase in resting fH could be caused by either
altered cholinergic or altered adrenergic autonomic nervous input to
the heart, or possibly by a cortisol-induced resetting of the cardiac
pacemaker (i.e. the spontaneous intrinsic fH). Pharmacological
agents were used to block muscarinic and β-adrenergic receptors to
evaluate cholinergic and adrenergic tone and intrinsic fH following
complete autonomic blockade (Altimiras et al., 1997). Indeed,
cholinergic tone was decreased in cortisol-treated fish (Fig. 4A),
whereas adrenergic tone and intrinsic fH were not significantly
altered (Fig. 4B). Thus, increased resting fH in cortisol-treated fish
originated from decreased cholinergic inhibition.
It is well known that factors such as blood viscosity and vascular
resistance affect theworkload of the heart. Elevated cardiac workload
could possibly mediate the cardiac enlargement observed following
cortisol treatment. Therefore, blood haematological variables such as
Hct and Hb content as well as haemodynamical variables such as
systemic blood pressure and vascular resistance (Rsys) were
investigated. Neither resting (Fig. 4C,D) nor maximum (Fig. 4E,F)
Hct and Hb levels differed between control and cortisol-treated fish,
indicating that blood viscosity was similar in the two groups.
Neither resting nor maximum PDA,sys, PDA,dia or mean PDA
differed significantly between treatment groups (Fig. S2), but
maximum Rsys was higher in cortisol-treated fish (Fig. 4H). Resting
Rsys was similar in the two groups (Fig. 4G).
As cardiovascular oxygen-transporting capacity is a strong
determinant of maximum aerobic swimming capacity in fish
(Claireaux et al., 2005), we also investigated whether the impaired
cardiac pumping capacity observed affected swimming performance.
This was tested in a separate cohort of fish treated with cortisol for
90 days [mean±s.e.m. CSI was 0.0782±0.003 versus 0.105±0.003 in
control (n=6) and cortisol-treated (n=10) fish, P<0.0001]. Ucrit was
reduced in the cortisol-treated fish, indicating that impaired cardiac
function translates to a reduced overall physical performance (Fig. 4I).
DISCUSSION
In the present work, we showed that exogenous cortisol
administration in rainbow trout induced substantial ventricular
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growth, probably through hypertrophy of the compact myocardium.
These larger hearts generated lowermaximum _Q andVS with reduced
_Q scope. At the molecular level, cortisol-induced hypertrophic
remodelling was associated with up-regulated signature genes of
mammalian pathological hypertrophy, indicating that intracellular
signalling pathways mediating cortisol-induced cardiac remodelling
in fish are similar to those involved in pathological cardiac
hypertrophy in mammals. Moreover, the observed cardiovascular
changes were linked to reduced aerobic swimming capacity.
Combined, our results are consistent with the hypothesis that
elevated cortisol causes non-adaptive pathological cardiac
hypertrophy, remodelling and dysfunction in rainbow trout.
The current findings are in line with our previous finding that
endogenous stress-induced cortisol production correlates with heart
size and remodelling in rainbow trout (Johansen et al., 2011). Our
previous investigations were performed on 40 month old (sexually
mature) adults that had spent their entire lives under rearing
conditions. It is therefore reasonable to assume that stress-induced
cortisol production is sufficient to induce myocardial growth and
remodelling in fish. Chronic stress has been shown to induce
increases in plasma cortisol levels comparable to those seen in the
current study in both magnitude and duration (Barton and Iwama,
1991; Wendelaar Bonga, 1997). Thus, we believe that the current
experimental protocol can be extrapolated to, for example, intensive
aquaculture conditions.
To our knowledge, only one previous study has investigated the
effect of chronic cortisol administration on cardiac performance in
fish. In line with our findings, Nesan and Vijayan (2012) reported
that embryo exposure to chronically increased cortisol levels leads
to cardiac performance dysfunction in zebrafish (Danio rerio). In
mammals, excessive glucocorticoids induce cardiomyocyte
hypertrophy both in vitro (Ren et al., 2012) and in vivo (de Vries
et al., 2002; Ahmed, 2013). Further, glucocorticoid-induced cardiac
hypertrophy in rat myocytes and myocardium is associated with an
increase in hypertrophy markers such as ANP and SMLC2 (De
et al., 2011; Ren et al., 2012).
In accordance with this, we found a consistent gene expression
up-regulation of signature molecules of mammalian hypertrophy
(i.e. ANP, SMLC2, MLP and RCAN1) in cortisol-treated rainbow
trout ventricles. Several of these hypertrophy markers serve as
specific molecular markers of pathological hypertrophy in humans.
For example, ANP and SMLC2 are part of the fetal gene programme,
which is reinitiated during pathological cardiac hypertrophy and
remodelling. Both genes are upregulated in pressure overload-
induced hypertrophy in rats (Schiaffino et al., 1989) and human
cardiac hypertrophy (Swynghedauw, 1999). Further, the cardiac
stress sensor MLP is upregulated in several models of heart disease
in rodents (Boateng et al., 2007) and is necessary for stress-induced
NFAT signalling (Heineke et al., 2003).
In mammals, extensive evidence exists that calcineurin–NFAT
signalling is essential for and activated in pathological hypertrophy
only (Wilkins et al., 2004). As NFAT is a transcription factor, its
activity can be measured by the mRNA expression of target genes,
e.g. RCAN1 (Rothermel et al., 2001). In the current study, cortisol
treatment induced an increase in RCAN1 mRNA expression, which
is in line with previous findings of increased RCAN1 expression in
rainbow trout with endogenously high plasma cortisol levels
(Johansen et al., 2011). Combined, these data indicate pro-
hypertrophic NFAT signalling in the rainbow trout heart in
response to chronic elevation of cortisol, and that NFAT
signalling in pathological cardiac hypertrophy is conserved from
fish to mammals.
It is reasonable to speculate that cortisol may be involved in
adaptive cardiac hypertrophy in salmonids under particular
circumstances. Upon salmonid sexual maturation and spawning
migration, plasma levels of corticosteroids peak (Schmidt and Idler,
1962). In fact, plasma levels of cortisol can be exceptionally high
during spawning migration (chronically up to 640 ng ml−1), similar
to those occurring during chronic stress (Carruth et al., 2000).
Interestingly, this hyper-activation of both the hypothalamus–
pituitary–interrenal (HPI) and hypothalamus–pituitary–gonadal
(HPG) axes during migration coincides with massive cardiac
growth. In contrast to the cardiac hypertrophy observed in the
current study, however, cardiac growth in migrating fish is
associated with improved mechanical performance and cardiac
pumping capacity (Franklin and Davie, 1992). One explanation
could be that cortisol serves as a pro-hypertrophic stimulus (Ren
et al., 2012), but that other factors (e.g. anabolic sex steroids) are
necessary for the hypertrophy to be accompanied by adaptive
changes such as increased force-generating capacity. Assuming
such a role for cortisol, large increases in cortisol under different
circumstances (such as during chronic stress) could potentially
remodel the heart in a non-adaptive manner similar to the current
observations. The exact combination of circumstances and exposure
levels promoting adaptive versus maladaptive cardiac hypertrophy
clearly deserves further scrutiny.
The mechanism by which cortisol and glucocorticoids induce
cardiac hypertrophy remains controversial. In mammals, cortisol
can induce cardiac hypertrophy signalling by directly binding to
nuclear receptors (ligand-inducible transcription factors) in the
cardiomyocyte. Ren et al. (2012) showed that as many as 75 genes
in the cardiac hypertrophy signalling pathway were altered by
in vitro glucocorticoid treatment. However, cortisol can also act
systemically by altering variables such as blood pressure, blood
viscosity and/or vascular resistance and thereby increase the
workload of the heart (Barton et al., 1987; Ahmed, 2013). We did
not find any indications of increased blood viscosity as neither Hct
nor Hb was altered by cortisol treatment.
In rodents, excessive glucocorticoids have been shown to induce
hypertension (Ahmed, 2013), which is a major risk factor for
pathological cardiac hypertrophy in mammals (Lloyd-Jones et al.,
2002). We did not see an increase in PDA. However, Rsys was
increased in cortisol-treated fish. Ventral aortic blood pressure and
branchial resistance are more direct measures of cardiac afterload,
but increased Rsys has been shown to increase ventral and dorsal
aortic blood pressure in trout (Conklin et al., 1997). Thus, our
findings suggest that the observed increase in Rsys plays a role in
mediating cardiac hypertrophy by elevating cardiac workload. In
addition, increased Rsys can partly explain the reduced _Q observed.
Interestingly, cortisol-treated fish appeared to compensate for the
reduction in _Q by increasing fH.
The increased fH could reflect increased catecholaminergic
innervation or decreased cholinergic tone on the heart. Reid et al.
(1996) showed that cortisol administration in rainbow trout altered
the secretion of catecholamines, which are well known for their
inotropic effects on the heart. By pharmacologically blocking both
adrenergic and cholinergic receptors, we found that the increased
fH in cortisol-treated fish was probably due to a reduction in
cholinergic tone rather than an increase in adrenergic signalling.
In summary, our results suggest a causative mechanism for the
previously observed association between endogenous stress
responsiveness and cardiac hypertrophy. This is the first study to
report and integrate the etiology, physiology and molecular biology
of cortisol-induced pathological remodelling in fish. Our data
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indicate that cortisol and probably also stress contribute to cardiac
pathology in teleosts. Further, our data indicate that gene activation
in pathological cardiac hypertrophy is evolutionarily conserved
between fish and mammals. This in turn actualizes the question of
why and how an apparently maladaptive trophic effect of an
otherwise catabolic hormone is preserved in both piscine and
tetrapod trajectories of vertebrate development.
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